Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Preclinical to clinical transl...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus

Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus

Bibliographic Details
Main Authors: Daniel S Strasser, Estelle Gerossier, Virginie Sippel, Ursula Grieder, Andrea Kieninger-Graefitsch, Sylvie Froidevaux, Marten Trendelenburg, Gabin M Pierlot, Enrico Vezzali, Anna K Stalder, Bérengère Renault, Jesper Ryge, Aaron Hart, Ulrich Mentzel, Peter M A Groenen, Marcel P Keller, Marianne M Martinic, Mark J Murphy
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/6/2/e001261.full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://rmdopen.bmj.com/content/6/2/e001261.full

Similar Items

  • Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P1 Receptor Modulator in Healthy Subjects
    by: Pierre-Eric Juif, et al.
    Published: (2017-12-01)
  • Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P1R Modulator, Are Not Affected by Ethnicity in Healthy Asian and White Subjects
    by: Pierre‐Eric Juif, et al.
    Published: (2021-01-01)
  • Autoantibodies against complement component C1q in systemic lupus erythematosus
    by: Marten Trendelenburg
    Published: (2021-01-01)
  • Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages
    by: Claudia Donat, et al.
    Published: (2019-11-01)
  • The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury—Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor
    by: Anneza Panagiotou, et al.
    Published: (2018-05-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...